April 2024 | AIChE

Other Sites & Tools

Technical Groups

You are here

April 2024

Ruchi Shah

Dr. Ruchi Shah is a seasoned professional with more than 10 years of experience in the field of nucleic acid delivery, gene editing, vaccines, vaccine adjuvant development, and biologics.

Ruchi started her career as Scientist at GSK Vaccines in 2015, focusing on mRNA -based liposomal vaccines. In the following year, she continued her path at Intellia Therapeutics in delivering CRISPR Cas9-based therapeutics with lipid nanoparticles and advanced fast to a Senior Scientist in non-viral...Read more

Ben Roose

Ben Roose, PhD is a Senior Scientist in the Vaccine Analytics Research & Development department at Merck based out of West Point, PA. He earned his bachelor’s degree in chemistry from Johns Hopkins University before pursuing his PhD in protein crystallography at the University of Pennsylvania. Since joining Merck, he has supported the advancement of the company’s RNA vaccine pipeline with a focus on characterizing mRNA drug substance. He has experience in analytical method development across a variety of techniques...Read more

September 2024 TSC Meeting

September 25, 2024
Virtual Meeting

September Meeting Time: 10:00 am - 12:00 pm (Eastern Daylight Time)

Nathan Duval

Nathan Duval is the Team Lead for the Technical Operations group at Nature’s Toolbox (NTx) in Rio Rancho, NM. Nathan earned a Ph.D. in Molecular Biology from the University of Denver. He spent time developing diagnostic tools using metatranscriptomic sequencing technologies at Viome prior to joining NTx. At NTx he has led the development of the NTxscribe® platform, a first of its kind, proprietary continuous-flow, in vitro transcription (IVT) system utilizing hollow fiber bioreactors. Nathan has managed external collaborations and...Read more

David Cirelli

David Cirelli is a Senior Director in Pfizer Inc.’s Analytical Research and Development department where he leads a group responsible for development of biological and impurity assays used in the characterization and quality control of Pfizer’s biotherapeutics and vaccine portfolio.  David has held various technical and leadership roles during his 22 year tenure in Pfizer/Wyeth/Genetics Institute research and development organizations. More recently, David led the COVID-19 mRNA vaccine analytical team responsible for technical strategy, method...Read more

David Mathews

David Mathews is the Lynne E. Maquat Distinguished Professor of RNA Biology at the University of Rochester.  He is in the Department of Biochemistry & Biophysics and the Center for RNA Biology.  He received his M.D. and Ph.D. from the University of Rochester, and his thesis work was mentored by Douglas Turner in Chemistry.  He was a postdoctoral fellow with David Case at the Scripps Research Institute.

The Mathews lab studies RNA structure using computational methods (...Read more

April 2024 CEP Preview

April 8, 2024
April 10, 2024

This issue, tips to better understand operating guidelines for utility water systems, considerations for designing thermoplastic piping systems, low- and mid-cost pollution sensors, and more.

Indorama Ventures

Empirisys

REXtac

Pages